Arkolith/Insider Trading/LRMR/Form 4

Deerfield Management Company, L.P. (Series C)

Director, 10% OwnerLarimar Therapeutics, Inc. (LRMR) · full profile →Form 4 · filed May 15, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 13, 2025Grant(A)19K—$019K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193805-25-000672) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML